|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1995-3-2
|
|
pubmed:abstractText |
Antimicrobial cationic peptides have been discovered in many different organisms and often possess a broad range of activity. In this study, we investigated the mechanisms of actions of melittin and two synthetic peptides, CEME (a cecropin-melittin hybrid) and CEMA, against gram-negative bacteria. CEMA was produced by recombinant DNA procedures and is an analog of CEME with a modified C terminus resulting in two additional positive charges. All three peptides showed good antimicrobial activity against four different gram-negative bacteria, but only CEMA was able to somewhat augment the activity of some conventional antibiotics in synergy studies. Studies using the bacteria Pseudomonas aeruginosa and Enterobacter cloacae showed that the peptides all possessed the ability to permeabilize bacterial outer membranes to the hydrophobic fluorophor 1-N-phenylnaphthylamine and the protein lysozyme, with CEMA being the most active. CEMA also had the strongest relative binding affinity for bacterial endotoxin (lipopolysaccharide). These data collectively indicated that these peptides all cross the outer membrane by the self-promoted uptake pathway and that CEMA is the peptide most effective at accessing this pathway.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-118160,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-1283347,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-1384706,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-1406489,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-1483838,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-1536865,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-15768483,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-1605597,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-169730,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-1720614,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-1915368,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-2178981,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-2187536,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-2228243,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-2455891,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-2580220,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-2646710,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-2668334,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-2990908,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-3013085,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-3032093,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-3125111,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-3128324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-3299384,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-3501699,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-3779000,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-4368713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-5592400,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-6093683,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-6269667,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-6409884,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-6414364,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-6433788,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-6440475,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-6794444,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-6803666,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-791092,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-7934902,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-8244033,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840562-8476558
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2311-6
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:7840562-Amino Acid Sequence,
pubmed-meshheading:7840562-Anti-Bacterial Agents,
pubmed-meshheading:7840562-Carrier Proteins,
pubmed-meshheading:7840562-Cell Membrane Permeability,
pubmed-meshheading:7840562-Lipopolysaccharides,
pubmed-meshheading:7840562-Melitten,
pubmed-meshheading:7840562-Molecular Sequence Data,
pubmed-meshheading:7840562-Peptides,
pubmed-meshheading:7840562-Pseudomonas aeruginosa,
pubmed-meshheading:7840562-Recombinant Fusion Proteins,
pubmed-meshheading:7840562-Recombinant Proteins,
pubmed-meshheading:7840562-Structure-Activity Relationship
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification.
|
|
pubmed:affiliation |
Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
